Yakup Ergün: Medical Oncology at Bower Hospital. OpenAlex indexes 118 publications with 551 citations (h-index 11).
Data verified 9 Nov 2026
Overview
Updated 9 Nov 2026
Yakup Ergün is Medical Oncologist at Bower Hospital. The public record shows 118 publications with 551 citations (h-index 11), centered on Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies, Gastric Cancer Management and Outcomes.
- Most recent indexed publication: 2026 · Journal of the National Cancer Institute
- Top research focus: Colorectal Cancer Treatments and Studies
Generated from the cited public record · current as of 9 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 32 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 15.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 9 Nov 2026
11 congress contributions (2019–2025) across ASCO, ESMO per OpenAlex. The most recent:
- Efficacy of anti-VEGF & anti-EGFRs in microsatellite instable (MSI-H) metastatic colorectal cancer, Turkish Oncology Group (TOG) study.
ASCO Annual Meeting
ASCO2025Co-author - 443P Efficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer
ESMO Congress
ESMO2023Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 9 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- RE: Endocrine Therapy in Early-stage Estrogen Receptor-Low Breast Cancer: A Systematic Review and Meta-Analysis.
Journal of the National Cancer Institute
Article2026 - Association Between ABO Blood Group and Survival Outcomes in Advanced NSCLC Treated with Immune Checkpoint Inhibitors.
Current oncology (Toronto, Ont.)
Article2026 - Comparative Safety Profiles of Sacituzumab Govitecan and Datopotamab Deruxtecan: A Real-World Pharmacovigilance Study.
Journal of clinical medicine
Article2026 - Efficacy and safety of omitting 5-fluorouracil bolus in combination chemotherapy regimens for gastrointestinal cancers: a systematic review and meta-analysis.
Expert opinion on drug safety
Meta-analysis2026 - Genomic divergence between matched primary and metastatic tumors across cancer types: a pan-cancer analysis of 5,692 samples.
Expert review of anticancer therapy
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 9 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH